Loading clinical trials...
Loading clinical trials...
Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study
Conditions
Interventions
Diosmin
Placebo
Locations
5
Canada
University of Calgary
Calgary, Alberta, Canada
Dalhousie University
Halifax, Nova Scotia, Canada
Saint Joseph Health Care Centre
London, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Mount Sinai Health System
Toronto, Ontario, Canada
Start Date
May 2, 2025
Primary Completion Date
July 15, 2027
Completion Date
August 15, 2027
Last Updated
December 4, 2025
NCT05878717
NCT06954597
NCT03211793
NCT04319120
NCT06697561
NCT03559465
Lead Sponsor
Primus Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions